Radioimmunotherapy With 90y-Ibritumomab Tiuxetan Is a Safe and Efficient Treatment for Patients With B-Cell Lymphoma Relapsed After Auto-Sct: An Analysis of the International RIT-Network
Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2010.202
Full Text
Open PDFAbstract
Available in full text
Date
September 27, 2010
Authors
Publisher
Springer Science and Business Media LLC